Last updated: February 19, 2026
Procainamide hydrochloride is a Class 1A antiarrhythmic agent used to treat cardiac arrhythmias. Key suppliers include both pharmaceutical manufacturers and chemical ingredient suppliers with global distribution networks.
Major Pharmaceutical Manufacturers
| Company |
Headquarters |
Production Capacity |
Certification |
Notes |
| Zhejiang Foxi Pharmaceutical Co. |
China |
High |
GMP |
Large-scale manufacturer, exports globally |
| Sandoz (Novartis) |
Switzerland |
Moderate |
GMP |
Produces branded and generic procainamide formulations |
| Yichang Humanwell Pharmaceutical |
China |
Moderate |
GMP |
Supplies active pharmaceutical ingredients (API) for domestic and export |
| Xianyang Pharmaceuticals |
China |
High |
GMP |
Engages in bulk API manufacturing |
Chemical Ingredient Suppliers
| Supplier |
Region |
API Production |
Certification |
Notes |
| Thermo Fisher Scientific |
Global |
Yes |
ISO, cGMP |
Offers procainamide hydrochloride API and research-grade compounds |
| Spectrum Chemical |
USA |
Yes |
ISO |
Supplies procainamide hydrochloride for research and clinical use |
| Tocris Bioscience |
UK |
Yes |
ISO |
Specializes in research-grade procainamide hydrochloride |
| Aladdin |
China |
Yes |
ISO |
Supplies for research, limited clinical batch production |
Global Distribution and Market Presence
- China: Dominates with several large-scale API producers, including Zhejiang Foxi and Yichang Humanwell. They supply both domestic pharmaceutical companies and export markets.
- Europe and USA: Manufacturing is primarily by multinational companies like Novartis (Sandoz) and suppliers such as Thermo Fisher Scientific, which target research and pharmaceutical manufacturing sectors.
- Regulatory Compliance: Major suppliers comply with GMP (Good Manufacturing Practice) standards. Certification from regulatory bodies such as the FDA, EMA, and China’s CFDA is common among leading producers.
Supply Chain Considerations
- API Quality: Possession of quality certifications (GMP, ISO) is critical for pharmaceutical manufacturing.
- Production Capacity: Large capacity manufacturers can meet global demand, especially during shortages or heightened need.
- Export Regulations: Some suppliers face export restrictions depending on origin or regulatory environment.
- Pricing: Variability exists; Chinese suppliers generally offer lower-cost API options, while Western suppliers provide higher quality assurance protocols.
Summary
Procainamide hydrochloride supply comes from several key regions, predominantly China and Europe/USA. Large-scale API producers such as Zhejiang Foxi and Yichang Humanwell dominate manufacturing capacity, while research-grade suppliers like Thermo Fisher Scientific serve research and clinical purposes globally. Regulatory compliance and certification status influence supplier choice for pharmaceutical companies.
Key Takeaways
- Leading API producers are located in China, with capacity for global distribution.
- Multinational pharmaceutical companies supply branded formulations.
- Supplier certification (GMP, ISO) is essential for pharma-grade procainamide hydrochloride.
- Supply chain disruptions may involve export restrictions and capacity constraints.
- Price differences depend significantly on geographic origin and quality certifications.
FAQs
-
Can I source procainamide hydrochloride directly from chemical suppliers?
Yes, for research and clinical trial purposes, suppliers like Thermo Fisher Scientific and Spectrum Chemical provide procainamide hydrochloride API.
-
Are there generic options available for procainamide hydrochloride?
Several generic manufacturers, primarily Chinese companies, produce procainamide hydrochloride API and formulations.
-
What quality certifications should I verify before purchasing procainamide hydrochloride for pharmaceutical manufacturing?
Ensure suppliers have GMP certification for pharmaceutical-grade API and ISO certification for quality standards.
-
What regions dominate the procurement of procainamide hydrochloride?
China is the primary source for bulk API, while Europe and the US supply research-grade compounds.
-
Are there potential supply chain risks for procainamide hydrochloride?
Yes, including export restrictions, geopolitical factors, and capacity limitations; evaluating supplier certifications mitigates some risks.
Citations
[1] U.S. Food and Drug Administration. (2022). Approved Drug Products with Therapeutic Equivalence Evaluations. Retrieved from https://www.fda.gov.
[2] European Medicines Agency. (2021). Chemical, Biological, Radiopharmaceuticals and Herbal Medicinal Products. https://www.ema.europa.eu.
[3] Zhejiang Foxi Pharmaceutical Co. Ltd. Official Website. (2023). Product portfolio. Retrieved from http://www.foxi.com.
[4] Spectrum Chemical. (2023). Procainamide Hydrochloride. https://www.spectrumchemical.com.
[5] Tocris Bioscience. (2023). Pharmaceutical and research chemicals. https://www.tocris.com.
